By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mundipharma International Limited 

Unit 220
Cambridge Science Park
Milton Road

Cambridge    CB4 0GW  England
Phone: 44-1223-424211 Fax: 44-1223-426626




Infinity Pharma 

Company News
Mundipharma International Limited Release: Penthrox (Low Dose Methoxyflurane) Granted Marketing Authorization In France 6/21/2016 10:32:38 AM
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014 2:39:05 PM
Mundipharma International Limited's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head its Corporate and Business Development 3/14/2012 6:45:44 AM
Horizon Pharma, Inc. Enters Into Exclusive Agreement With Mundipharma International Limited for Commercialization of LODOTRA(R) (Modified-Release Prednisone) in Latin America 3/7/2012 8:49:50 AM
Infinity Pharmaceuticals Inc. (INFI) Gets $50 Million More in Mundipharma International Limited Deal 11/29/2011 7:02:20 AM
Mundipharma International Limited Release: New Research Shows Chronic Pain is not Being Adequately Measured[1] 10/10/2011 11:35:28 AM
Infinity Pharmaceuticals Inc. (INFI) and Mundipharma International Limited Extend Global Strategic Alliance; Mundipharma Commits to Providing Up to $110 Million for 2012 12/13/2010 11:55:40 AM
Infinity Pharmaceuticals Inc. (INFI) Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Limited Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide 10/26/2010 8:56:25 AM
Mundipharma International Limited: Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers 3/19/2010 10:44:57 AM
Novelos Therapeutics, Inc. and Mundipharma International Limited Sign Exclusive Collaboration Agreement in Europe and Japan; Deal Potentially Worth $95 Million 2/12/2009 7:43:11 AM